ISO-certified laboratory analyses 🇩🇪

Lipopolysaccharides explained simply: what LPS mean in the gut

The essentials at a glance

Lipopolysaccharides, or LPS for short, are building blocks of the outer envelope of certain bacteria. They are neither foreign bodies nor invaders, but a constant component of a normal gut microbiota. A single cell of the gut bacterium Escherichia coli carries around two million of these molecules on its surface (Rhee, 2014).

This article explains the technical term as biochemistry describes it and separates it from the interpretations that have grown around it online. Where a source cites a number, it is listed here with the authorship and year. Where no source is available, that is also stated.

You will first learn what LPS are and where they are located. This is followed by the symptoms that require a visit to a doctor’s office, the structure of the molecule, four common statements examined against the facts, and the question of what testing your gut microbiota can reveal about it. The limitations come at the end.

What to expect in this article

1. What lipopolysaccharides are—and why the term is suddenly appearing everywhere
2. Where LPS are located in your gut
3. When abdominal symptoms belong in a doctor’s office
4. What an LPS molecule is made of
5. Four statements about LPS and what remains of them
6. How your immune system detects LPS in the first place
7. What a microbiome test result says—and does not say—about LPS
8. How you can have your gut microbiota tested at home
9. Which question is suited to which approach
10. Limitations: what cannot currently be said about LPS
11. Who can benefit from having their gut microbiota tested
12. What really matters about LPS
Frequently asked questions
Sources

What lipopolysaccharides are—and why the term is suddenly appearing everywhere

Lipopolysaccharides are large molecules made up of two very different parts: a lipid component and a sugar component. That is exactly where the name comes from. The Greek lipos means fat, while polysaccharide means a long chain of sugar units.

These molecules are located in the outer membrane of Gram-negative bacteria. Gram-negative is a classification based on a staining method from the 19th century that still describes how a bacterial envelope is built today. Bacteria in this group have two membranes instead of one, and LPS form the outer layer of the outer membrane.

In the scientific literature, LPS have a second name: endotoxin. The word is misleading if taken literally. It does not mean that a bacterium produces and excretes a toxin, but that the substance is part of the cell itself. An endotoxin is building material, not a secretion.

Key takeaway

Lipopolysaccharides are not a metabolic byproduct that bacteria secrete, but part of their cell envelope—they belong to the organism’s blueprint, not its waste.

Why the cell envelope is built this way in the first place

For the bacterium, this layer serves a purpose that has nothing to do with humans. The tightly packed lipid components make the outer membrane difficult to permeate. As a result, substances that could harm the cell have more difficulty getting inside.

In the language of this house’s voice rules: The LPS layer is the building’s outer wall, not the garbage standing in front of it. It holds together what belongs together and keeps out what does not belong inside.

The fact that the human organism reacts to this structure is a second, independent circumstance. It is explained in Chapter 6. For now, the key point is this: LPS do not exist to harm anyone, but because a bacterium needs an envelope.

What Distinguishes Gram-Negative from Gram-Positive Bacteria

The classification goes back to the Danish bacteriologist Hans Christian Gram, who developed a staining method in 1884. He was looking for a way to make bacteria visible in tissue samples and, in the process, encountered a difference he himself could not yet explain.

Some bacteria retained the blue-violet dye even after washing, while others lost it again. The former have been called gram-positive ever since, and the latter gram-negative. Only much later did it become clear that this reflected two fundamentally different types of cell-envelope structure.

Gram-positive bacteria have a thick layer of a mesh-like material that retains the dye. Gram-negative bacteria have only a thin layer of it, but also an additional outer membrane over it. The lipopolysaccharides are located precisely in this additional membrane.

This establishes the connection that underpins the entire article: Where LPS are found, there is a gram-negative bacterial envelope. A 140-year-old staining method from microscopy still describes which bacteria carry these molecules and which do not.

Why the Term Suddenly Appears in Health Advice Articles

LPS is an old term in microbiology and was a subject for intensive-care specialists for decades. In recent years, it has made its way into health advice articles, usually in connection with intestinal permeability.

A shortening regularly occurs here. A molecule that can trigger a strong reaction in the bloodstream becomes, in the summary, a substance that must be eliminated. The entire difference between academic literature and interpretation lies between these two sentences.

Where LPS Are Located in Your Gut

In the large intestine of every healthy person, gram-negative bacteria live. They are part of the normal microbiota, and their LPS are therefore also a normal component of the gut. A gut without lipopolysaccharides would not be a healthy gut, but a sterile one.

Documented source

“The gut flora also protects against other harmful bacteria colonizing and multiplying in the gut.”

Institute for Quality and Efficiency in Health Care (IQWiG)
How the Gut Works, as of 2026

The sentence describes a protective effect arising from the colonization itself. Bacteria that occupy a space keep others away. The LPS-carrying species participate in this colonization; they are not exempt from it.

IQWiG describes the gut flora in the same passage as billions of bacteria that feed on the indigestible components of food and produce vitamins B and K in the process (2026). Gram-negative species also contribute to this.

Which bacterial groups in the gut carry LPS

The gut flora of an adult is shaped by two major groups of bacteria: Firmicutes and Bacteroidetes. They differ in many respects, including the structure of their cell envelopes.

Bacteroidetes are gram-negative bacteria and therefore carry lipopolysaccharides. Firmicutes are predominantly gram-positive and do not carry them. Both groups belong in every healthy gut, and both perform functions there.

The ratio of these two groups to each other is therefore a common metric in microbiome reports. The Microbiome Gut Test reports it as the Firmicutes-to-Bacteroidetes ratio. What this value does and does not mean is explained in Chapter 7.

At this point, only the connection matters: Some of the bacteria in your gut carry LPS because it is part of their outer layer. This is not an abnormality but the normal state of a mixed microbial community.

The separation between intestinal contents and the bloodstream

A location is crucial to understanding this. LPS in the intestinal contents and LPS in the bloodstream are two entirely different situations, even though they are the same molecule.

Inside the intestine, they are part of everyday life. The intestinal lining is specifically designed to separate the contents from the tissue. The mucosal immune system recognizes the bacteria that reside there and responds to them cautiously; otherwise, permanent colonization would not be possible.

The situation is different in the bloodstream, and that is also where the knowledge that made the term famous comes from. In their overview for StatPearls (2023), Aisha Farhana and Yusuf S. Khan describe how fragments containing Lipid A that enter the circulation cause fever and diarrhea and, under unfavorable circumstances, can lead to septic shock.

This describes an acute clinical situation of the kind encountered in intensive care medicine. It does not describe the everyday experience of someone with bloating. Conflating the two in a single sentence turns an emergency presentation into a routine diagnosis.

When abdominal symptoms require a visit to a doctor’s office

This chapter deliberately comes before all further explanations. A text that places the stop criteria at the end fails to reach precisely the reader they are intended for.

These signs require medical evaluation

Blood in the stool

regardless of the amount and regardless of whether pain is present

Unintentional weight loss

without an apparent reason, especially over the course of just a few weeks

Fever together with abdominal symptoms

especially if it persists for days

Persistent diarrhea lasting for weeks

or a nighttime urge to have a bowel movement that regularly wakes you

Paleness and pronounced exhaustion

that do not improve with rest

These points follow IQWiG's classification of irritable bowel syndrome, according to which symptoms such as substantial weight loss, blood in the stool, fever, or paleness are more likely to indicate another intestinal disease (2023).

The list is not a diagnostic checklist and does not replace an examination. It marks the point at which focusing on a technical term would be the wrong answer to the right question. Anyone who notices warning signs should not take a test, but make an appointment.

A single item on this list means little on its own. The picture becomes concerning when several apply at the same time or when one of them persists for weeks. Everything else in this article assumes that this question has been clarified.

Chapter at a glance

Abdominal discomfort with blood in the stool, unintentional weight loss, fever, diarrhea lasting for weeks, or pronounced paleness should be medically evaluated before an examination of the gut microbiota is considered at all. According to IQWiG, these signs are more likely to indicate another intestinal disease (2023). The order is: first the appointment, then the detailed search for the cause.

What an LPS molecule consists of

A lipopolysaccharide consists of three sections that follow one another like the floors of a building. They differ in their structure, location, and the extent to which the human body reacts to them.

Section 1

Lipid A—the lipid anchor

Anchors the molecule in the membrane. The part to which the immune system reacts.

Section 2

Core oligosaccharide

A short sugar segment in the middle. It connects the lipid anchor to the long outer chain.

Section 3

O antigen

The long sugar chain extending outward. It differs from one bacterial species to another.

According to Rhee (2014), the outer chain, the O antigen, generally consists of twenty to forty repeating sugar units. Its composition varies from species to species and has long been used in microbiology to distinguish bacterial strains from one another.

The core and the KDO sugar

The middle section is the least conspicuous and, at the same time, the component without which the molecule would not hold together. Rhee (2014) divides it into an inner and an outer core.

A special sugar, abbreviated KDO, connects it to the lipid anchor. It contains eight carbon atoms and, in this form, occurs almost exclusively in bacteria. Further sugars follow in the outer core, including glucose and galactose.

This is interesting in practice for one reason: Because KDO does not occur in humans, it can be used in a sample to distinguish what comes from bacteria and what does not. Such markers form the basis of many microbiological detection methods.

This is also why antibiotic research is interested in this section. A substance that blocks the production of KDO would target a structure that does not exist in the human body.

Why lipid A is specifically responsible for the effect

Of the three sections, lipid A is the one that determines the human body’s response. In their review, Farhana and Khan describe it as the most bioactive component of the molecule (StatPearls, 2023).

How strong this effect is depends on a surprisingly specific factor: the number of fatty acid chains. Rhee (2014) describes lipid A with six chains as showing full activity, one with five chains as being roughly one hundred times weaker, and one with four chains as losing its triggering effect entirely.

This leads to a point that is almost never mentioned in informational texts. LPS is not a single uniform substance but a family of molecules with very different potencies. Different bacterial species construct their lipid A differently, so the question of quantity alone is never the whole question.

The scale on a single cell

According to Rhee (2014), a cell of Escherichia coli, one of the best-known gut bacteria, carries around two million LPS molecules. Together, they form the entire fatty layer of the outer half of the membrane.

This number makes clear why the idea that LPS could be removed from the gut misses the point. They are not a coating on the bacteria. They are the bacteria’s outer wall.

Four statements about LPS and what remains of them

The following four statements appear in many texts on the subject. They sound plausible, and each contains a kernel of truth. But none holds up in the form in which it is usually presented.

Checked against the evidence

Widespread

“LPS are toxins that should be removed from the gut.”

Documented

LPS are components of the outer membrane of Gram-negative bacteria (Farhana and Khan, StatPearls, 2023). A single cell carries around two million of them (Rhee, 2014). Removing them would mean removing the bacteria.

Widespread

“An LPS level in my blood shows how permeable my intestinal wall is.”

Documented

Such a measurement is not part of routine diagnostics. A microbiome analysis does not measure it either: LPS does not appear on any marker list on the product page for the Microbiome Gut Test (checked live on 27 August 2026).

Widespread

“Endotoxin means that bacteria secrete a toxin.”

Documented

Endotoxins are not secreted; they are part of the cell envelope. Lipid A is released in fragments only when a bacterial cell disintegrates (Farhana and Khan, StatPearls, 2023).

Widespread

“All LPS have the same potency.”

Documented

The potency depends on the structure of lipid A. Six fatty acid chains result in full activity, five in roughly one hundred times less, and four in no triggering effect at all (Rhee, 2014).

All four sentences reflect a genuine need. Anyone who has felt bloated and tired for months is looking for an explanation, and a technical term containing the word toxin sounds like one. The need is legitimate; the shortcut to it is not.

How your immune system notices LPS at all

The human body has its own recognition system for LPS. It does not consist of a single receptor but of a chain of four participants that act in sequence.

Rhee (2014) describes this chain as follows: A binding protein in the blood attaches to lipid A. A second molecule called CD14 takes over and passes it on. A third, MD-2, enables binding to the actual receptor, Toll-like receptor 4. Only then does a signal begin inside the cell.

The fact that the body recognizes something does not mean that it fights it.

The fact that the body recognizes something does not mean that it fights it. Recognition is initially merely awareness, comparable to a doorman who registers everyone entering the building and simply waves most of them through.

Why this chain exists at all

A recognition system for bacterial envelopes is evolutionarily ancient and present in many animal groups. It belongs to the innate defenses, that is, the part of the immune system that functions without prior contact.

The point is obvious: When bacterial envelopes appear in places where they do not belong, something has happened. An injury, an infection, a breach. The system reports a change of location, not a substance.

That is precisely why the location specified in Chapter 2 is so important. The same structure that is part of everyday life inside the intestine is a signal in the tissue. The molecule has not changed; its address has.

Why the intestinal lining responds cautiously

If the body has a recognition system for LPS and LPS is constantly present in the intestine, a question naturally arises: Why does a defensive reaction not run continuously there?

The answer lies in the design of the boundary surface. The cell layer separating the intestinal contents from the tissue is covered with a layer of mucus, and the immune cells residing there operate with different thresholds from those in the blood. What lies in the intestinal lumen does not trigger the same reaction there as the same molecule does in the tissue.

This restraint is not a weakness but an achievement. An immune system that reacted to every bacterial envelope in the intestine would make permanent colonization impossible—and therefore also the protective effect that IQWiG attributes to the gut flora.

The objection is justified: This is exactly where the texts that speak of a permeable intestinal wall begin. The idea is understandable. But the question of when a boundary surface should be considered permeable and how this could be determined in an individual case remains unanswered.

What this means for self-interpretation

The presence of a recognition system does not allow any conclusion to be drawn about an individual's condition. Toll-like receptor 4 is present in everyone, and everyone encounters LPS.

Anyone who wants to know what their gut microbiome is made up of cannot get any further through this chain. They need a test of the bacteria themselves. What such a test can and cannot do is explained in the next chapter.

What a microbiome test report does and does not say about LPS

This is the most important statement in this article, and it runs counter to the obvious sales pitch: A gut microbiome test does not measure lipopolysaccharides. It determines which bacteria are present, not which molecules their outer membranes carry.

The connection is indirect. Anyone who learns which bacterial groups are present in what proportions also learns something about what proportion belongs to the gram-negative species. That does not constitute a statement about the amount of LPS.

The following table compares three ways of addressing the question of LPS. They are not mutually exclusive, but they answer different questions.

Criterion Medical evaluation Gut microbiome test Just keep reading
Question answered Is an illness causing my symptoms? What is my gut microbiome made up of? What does the term I read mean?
Measures LPS Not as part of routine testing No, explicitly not No
Provides a diagnosis Yes, that is its purpose No No
Time required Appointment, waiting time, and, if necessary, follow-up examination Kit shipping: 1–3 business days, laboratory analysis: 5–10 business days Half an hour

A test report describes a condition, not a cause. That is why medical evaluation appears in the first column rather than the last.

How this article differs from its neighboring articles

This text explains a technical term and nothing else. Anyone who wants to know what species diversity in a report means can find that information in Microbiome Diversity in a Test Report. Anyone interested in the concept of intestinal permeability can find the explanation in Leaky Gut Syndrome Test.

Which bacterial species and markers can actually appear in a gut microbiome test can be looked up in advance: the Gut Microbiome Lexicon lists them in a searchable overview. Lipopolysaccharides are not included, and that is the most honest answer to the original question.

How to have your gut microbiome tested at home

If, after reading the text so far, the question remains which bacteria live in your gut, it can be answered with a stool sample. The mybody®x Complete gut microbiome test (MYBODY Lab GmbH) reads the genetic material of the microorganisms in the sample.

What does not come out of it is stated on the card itself. This information is more important than any sales argument that could be built from this article.

Complete gut microbiome test by mybody®x (MYBODY Lab GmbH)

Gut test from a stool sample

Gut microbiome test | Complete

Records more than 1,500 bacterial species through DNA sequencing, along with biodiversity, enterotype, FODMAP index, and eight bioindicators. What the test does not do: It measures no lipopolysaccharides—LPS does not appear in any marker list on the product page. It also does not provide a diagnosis or detect inflammatory bowel disease, tumors, infections, or celiac disease.

Price €189.00 As of 27 August 2026, subject to change
Sample type Stool sample
Processing time Kit shipping: 1–3 business days
Laboratory analysis: 5–10 business days after receipt of the sample
Laboratory certified specialist laboratory
Information from the product page, accessed 27 August 2026
To the Gut Microbiome Test

The figure of more than 1,500 bacterial species comes from the product page. Which species and markers these are specifically is listed in the gut microbiome glossary, which makes the underlying database searchable.

Which question fits which approach

Most people who search for lipopolysaccharides do not really have a question about biochemistry. They have symptoms and came across the term while looking for an explanation.

In this case, the order matters more than the choice. First, go through the warning signs in Chapter 3. If any apply, seeing a doctor is the first step and everything else can wait.

If none of these apply and the symptoms have persisted for months, a gut microbiome assessment may be a possible second step. It does not provide an LPS value or a diagnosis, but a description of what is present.

What you can do without any measurements

For many people, the most useful step is not a test but a record. For two to four weeks, noting when specific symptoms occur and what was eaten on the same day costs nothing and provides something no test result can: a temporal connection.

The reason is simple. A laboratory result describes a condition; a record describes a course over time. For the question of why you feel worse on some days than on others, the course over time is the more useful information.

Such a record also shortens the doctor’s consultation. Anyone who brings it along does not have to reconstruct from memory how often something occurred.

Why a second measurement tells you more than the first

The composition of the gut microbiome changes with diet, medication, age, and stress, and does so within weeks. A single report therefore describes a point in time, not a permanent state.

If you change something and want to see the effect, measure beforehand and again after about three months. Only comparing two reports shows a direction. However, the comparison presupposes that you know what you changed in the meantime.

Limitations: what cannot currently be said about LPS

The limitations in this area are unusually broad, and they belong visibly in the text rather than in a footnote at the end.

As for the amount of LPS normally found in the intestine of a healthy person, no figure from a German institution is available. That is why this article does not give a number. An estimate would be the worse mistake.

The same applies to the question of whether and how a change in diet affects LPS. What can be changed is the composition of the bacteria. What this means for individual molecules in their cell walls remains unanswered.

The figures in this text come from two specialist publications and describe molecular structure and recognition. They are not measurements from humans and cannot be translated into an individual test result.

And the test itself has the limitation stated in the product information: It does not measure LPS. Anyone looking for a number for lipopolysaccharides will not find it there—and no one should buy a test to get an answer to a question it cannot answer.

Who a gut microbiome analysis is useful for

Useful for you if …

your symptoms have persisted for months, have been medically evaluated, and you are looking for a baseline assessment.

you are planning to change your diet and want to monitor the course with one measurement beforehand and another after three months.

you want to see what your gut microbiome currently consists of after antibiotic treatment.

Probably not if …

you are expecting an LPS value or an endotoxin figure. Neither appears in any report from this test.

you notice one of the warning signs from Chapter 3. In that case, seeing a doctor is the right first step, not taking the test.

you are hoping for a diagnosis. An analysis of the gut microbiome provides a description, not a disease diagnosis.

What really matters about LPS

If you take away one single thought from this article, let it be this: With lipopolysaccharides, it is not the amount but the location that matters. The same molecule is part of the normal state inside the intestine and a signal in tissue.

In practice, this means that none of the questions people ask about LPS can be answered with an LPS level. The real questions are: Where are my symptoms coming from, and what can I change? Both lead to medical evaluation and an assessment of the composition of the gut flora, not to a single molecule.

It all began with the question of what lipopolysaccharides actually are. The most honest answer is: the outer wall of your roommates. And you do not remove an outer wall; you look at who lives behind it.

Frequently asked questions

What are lipopolysaccharides, simply explained?

Lipopolysaccharides, or LPS for short, are large molecules made up of a lipid component and a sugar chain. They form the outer layer of the cell envelope of gram-negative bacteria. A single Escherichia coli cell carries around two million of them (Rhee, 2014). LPS are not released by bacteria; they are building material for their outer layer. In technical terminology, they are also called endotoxins.

Are LPS dangerous in the gut?

Inside the intestine, LPS are part of the normal state because gram-negative bacteria are among the usual residents. IQWiG describes the gut flora as billions of bacteria that protect against the colonization of harmful microbes (2026). The situation is different when fragments containing lipid A enter the bloodstream: That describes an acute clinical situation in intensive care medicine (Farhana and Khan, StatPearls, 2023), not everyday life.

Can a microbiome test measure my LPS?

No. The Microbiome Gut Test identifies more than 1,500 bacterial species as well as biodiversity, enterotype, the FODMAP index, and eight bioindicators. Lipopolysaccharides do not appear on any of these marker lists, as verified on the product page on 27 August 2026. The report therefore indicates which bacteria are present, not how much LPS their outer layers carry.

What is the difference between an endotoxin and an exotoxin?

An exotoxin is produced by a bacterium and released outward. An endotoxin, by contrast, is part of the cell itself. LPS belong to the second group: They are located in the outer membrane and are released only in fragments when a bacterial cell breaks down (Farhana and Khan, StatPearls, 2023). Here, the word component “toxin” therefore describes not secretion, but a possible effect.

Why don’t all LPS have the same potency?

Because the lipid A anchor differs between bacterial species. What matters is the number of fatty acid chains: six chains produce full activity, five are around a hundred times weaker, and with four chains the triggering effect disappears completely (Rhee, 2014). LPS are therefore not a uniform substance, but a family of molecules with very different potencies.

Next step

Look it up first, then decide

Before deciding to undergo an examination, you can check the Gut Dictionary to see which bacterial species and markers a report contains at all. If you then want an overview of your gut microbiome, you can find it in the Gut Microbiome Test.

To the Gut Dictionary To the Gut Microbiome Test

Read more

You may also be interested in

Microbiome diversity in a report: what the value really indicates

What the diversity of species in a report means and why a high value alone is not conclusive.

Leaky Gut Syndrome Test – Find clarity for your gut

The classification of the term most frequently mentioned alongside LPS in texts.

Gut Dictionary: Discover all the bacteria and markers in your gut flora

The searchable overview of all markers that may appear in a report.

Sources

  1. Institute for Quality and Efficiency in Health Care (IQWiG): How does the gut work? (as of 2026) – gesundheitsinformation.de
  2. Institute for Quality and Efficiency in Health Care (IQWiG): Irritable bowel syndrome (as of 2023) – gesundheitsinformation.de
  3. Sang Hoon Rhee: Lipopolysaccharide: Basic Biochemistry, Intracellular Signaling, and Physiological Impacts in the Gut. Intestinal Research 12(2), 2014, pages 90–95 – pmc.ncbi.nlm.nih.gov
  4. Aisha Farhana and Yusuf S. Khan: Biochemistry, Lipopolysaccharide. StatPearls Publishing, as of 2023 – ncbi.nlm.nih.gov

The verbatim quotation on the protective effect of the gut flora, as well as the information on billions of bacteria and the production of vitamins B and K, comes from source [1]. The warning signs in Chapter 3 follow the classification in [2]. The figure of around two million LPS molecules per cell, the twenty to forty sugar units of the O antigen, the gradation of potency according to fatty acid chains, and the recognition chain consisting of binding protein, CD14, MD-2, and Toll-like receptor 4 come from [3]. The classification of lipid A as the most bioactive component, the distinction between endotoxin and exotoxin, and the description of the reaction in the bloodstream come from [4]. Information on price, marker scope, sample type, and laboratory comes from the mybody®x product page, accessed on 27 August 2026; processing times follow the central specification for gut tests. All sources were accessed and checked on 27 August 2026.

mybody®x (MYBODY Lab GmbH) Certificate / Quality Seal

mybody®x Editorial & Specialist Team

Microbiome science Laboratory diagnostics Gut science Nutritional science

This article was created by the mybody®x editorial and specialist team. The team combines microbiome and gut science, laboratory diagnostics, and nutritional science. Those who contribute to it are listed on the authors page.

Published on 27 August 2026 · Last updated on 27 August 2026

The content is for general information only and does not replace medical advice, diagnosis, or treatment. Reference ranges depend on the laboratory, method, and age—the information on your report is always authoritative.

mybody®x (MYBODY Lab GmbH) Certificate / Quality Seal

Latest posts

Show all

Eine gusseiserne Kettlebell neben einer Handvoll Kichererbsen und einem indigoblauen Leinentuch auf rohem Holz.

Muskeln aufbauen und Fett abbauen gleichzeitig: geht das? Sechs messbare Hebel

Muskeln aufbauen und Fett abbauen gleichzeitig: geht das? Sechs messbare Hebel Das Wichtigste in Kürze Ja, beides zugleich ist möglich. In der Sportwissenschaft heißt der Vorgang Körperrekomposition oder body recomposition, also Muskelaufbau bei gleichzeitigem Fettabbau. Am ehesten gelingt er Einsteigern...

Read more

Eine dunkle Schüssel mit Erdnüssen in der Schale, eine angebrochene Tafel dunkler Schokolade und zwei Reiswaffeln auf Leinen.

Snacks, die dein Partner nicht verträgt: Allergie oder Unverträglichkeit?

Snacks, die dein Partner nicht verträgt: Allergie oder Unverträglichkeit? Das Wichtigste in Kürze Allergie und Unverträglichkeit sind zwei verschiedene Vorgänge. Bei einer Allergie reagiert das Immunsystem auf ein Eiweiß, und bei manchen Lebensmitteln reichen dafür sehr kleine Mengen. Bei einer...

Read more

Mann Mitte vierzig steht morgens in seiner Küche am Fenster, daneben ein Glas Wasser und eine Schale Obst.

Testosterone levels: Which everyday factors really lower them

Testosterone levels: Which everyday factors really lower them The essentials at a glance Four everyday factors are the best documented: too little sleep, belly fat, regular alcohol consumption, and prolonged strain. Certain medications and the normal decline with age also...

Read more